157 related articles for article (PubMed ID: 16718959)
21. Relation between physician characteristics and prescribing for elderly people in New Brunswick.
Davidson W; Molloy DW; Somers G; Bédard M
CMAJ; 1994 Mar; 150(6):917-21. PubMed ID: 8131124
[TBL] [Abstract][Full Text] [Related]
22. Physicians, the industry and population health.
Gérvas J; Mansfield PR
J Epidemiol Community Health; 2009 Oct; 63(10):773-4. PubMed ID: 19749125
[No Abstract] [Full Text] [Related]
23. Physician specific prescribing information.
Somberg J
Am J Ther; 2006; 13(6):465. PubMed ID: 17122524
[No Abstract] [Full Text] [Related]
24. [Evaluation of prescription practices and of the rational use of medicines in Niger].
Mallet HP; Njikam A; Scouflaire SM
Sante; 2001; 11(3):185-93. PubMed ID: 11641083
[TBL] [Abstract][Full Text] [Related]
25. A 'compass' for general practitioner prescribers.
McGavock H; Wilson-Davis K; Rafferty T
Health Trends; 1994; 26(1):28-30. PubMed ID: 10136287
[TBL] [Abstract][Full Text] [Related]
26. Statistics and drug utilization: are prescribing rates really that high?
Morgan S
CMAJ; 2001 Nov; 165(11):1507-8. PubMed ID: 11762577
[No Abstract] [Full Text] [Related]
27. Antibiotic prescribing rates.
Potter PJ
CMAJ; 1999 Aug; 161(3):245-6. PubMed ID: 10463042
[No Abstract] [Full Text] [Related]
28. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
Brand R
State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
[No Abstract] [Full Text] [Related]
29. Effect of interactive group discussion among physicians to promote rational prescribing.
Garjani A; Salimnejad M; Shamsmohamadi M; Baghchevan V; Vahidi RG; Maleki-Dijazi N; Rezazadeh H
East Mediterr Health J; 2009; 15(2):408-15. PubMed ID: 19554988
[TBL] [Abstract][Full Text] [Related]
30. Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".
Huddle TS
Am J Bioeth; 2010 Jan; 10(1):W1-3. PubMed ID: 20077322
[No Abstract] [Full Text] [Related]
31. The devil in the detail(ing).
Morreim H
Am J Bioeth; 2010 Jan; 10(1):15-7. PubMed ID: 20077328
[No Abstract] [Full Text] [Related]
32. The economic aspects of drug use.
Haaijer-Ruskamp FM; Dukes MN
WHO Reg Publ Eur Ser; 1993; 45():125-45. PubMed ID: 8442842
[No Abstract] [Full Text] [Related]
33. Drug makers battle a U.S. plan to curb rewards for doctors.
Pear R
N Y Times Web; 2002 Dec; ():A1, A28. PubMed ID: 12561833
[No Abstract] [Full Text] [Related]
34. Public information on private practice: the availability of physician inpatient data.
Hughes RG; Lee DE
Hosp Health Serv Adm; 1990; 35(1):55-69. PubMed ID: 10103692
[TBL] [Abstract][Full Text] [Related]
35. Why academic medical centers should ban drug company gifts to individuals.
Strong C
Am J Bioeth; 2010 Jan; 10(1):13-5. PubMed ID: 20077327
[No Abstract] [Full Text] [Related]
36. Huddle gets it right, most docs don't.
Rubin PH
Am J Bioeth; 2010 Jan; 10(1):17-9. PubMed ID: 20077329
[No Abstract] [Full Text] [Related]
37. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
Poser S
Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
[No Abstract] [Full Text] [Related]
38. Strategies for safe and cost-effective pharmaceutical care.
Med Manag Netw; 1999 Sep; 7(9):1-4. PubMed ID: 10558152
[No Abstract] [Full Text] [Related]
39. The details are in the field.
Schwab AP
Am J Bioeth; 2010 Jan; 10(1):19-21. PubMed ID: 20077330
[No Abstract] [Full Text] [Related]
40. Avoiding over-deterrence in managing physicians' relationships with industry.
Stell LK
Am J Bioeth; 2010 Jan; 10(1):27-9. PubMed ID: 20077334
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
